Adverse Events of Abiraterone Acetate Versus Enzalutamide.

In conclusion, our findings suggest that both drugs present a discrete and non-overlapping toxicity profile that varies by SOC and patient age. This dataset confirms, for the most part, what has been reported in clinical trials as well as true real-world reports.